We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MVNE:TASEMivne Real Estate (K.D) Ltd. Analysis

Data as of 2026-06-04 - not real-time

ILA 1,385.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

MVNE trades at 1,385 ILA, delivering a trailing PE of 14.6—well below the industry average of 31.9—suggesting significant valuation headroom, further underscored by a 19% upside potential from the DCF model. Margins remain robust, with a gross margin of 68% and operating margin above 60%, while the dividend yield of 1.76% is supported by a modest 10% payout ratio and strong operating cash flow. However, revenue has contracted 27% year‑over‑year, and the balance sheet carries a high debt‑to‑equity ratio of 103%, flagging leverage concerns. The stock’s beta of 0.59 indicates lower market sensitivity, yet a 30‑day volatility of 34% and a recent max drawdown of 22% point to notable price swings. The company’s free cash flow of roughly 648 million ILA provides a cushion for dividend payments and potential deleveraging. Its diversified portfolio across Israel, Europe and North America reduces single‑country exposure but introduces geopolitical and currency considerations.
Technically, the price sits just above the 1,363 support level and below the 1,625 resistance, with the 20‑day SMA (1,489) above both the 50‑day (1,433) and 200‑day (1,403) averages, signalling a bullish trend despite a bearish MACD histogram and a sub‑50 RSI of 38. Volume is trending downwards, and the market sentiment is marked by an “Extreme Greed” reading on the fear‑greed index, suggesting short‑term optimism that may be tempered by the weakening momentum indicators. The decreasing daily volume, currently under 1 million shares versus a 10‑day average of 1.7 million, hints at waning trader interest. Given the high leverage, any further earnings deterioration could pressure the dividend sustainability despite the low payout. Overall, the mix of undervaluation, solid cash generation and elevated debt creates a nuanced risk‑reward profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support at 1,363
  • bearish MACD histogram
  • decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE well below industry average
  • 19% upside potential
  • stable dividend yield

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • high debt‑to‑equity ratio
  • negative revenue growth
  • diversified geographic footprint

Key Metrics & Analysis

Financial Health

Revenue Growth-26.80%
Profit Margin48.24%
P/E Ratio14.6
ROE7.20%
ROA2.36%
Debt/Equity103.54
P/B Ratio1.1
Op. Cash FlowILA899.2M
Free Cash FlowILA647.8M
Industry P/E31.9

Technical Analysis

TrendBullish
RSI38.7
SupportILA 1,363.00
ResistanceILA 1,625.00
MA 20ILA 1,488.80
MA 50ILA 1,432.84
MA 200ILA 1,402.77
MACDBearish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair ValueILA 97.86
Target PriceILA 1,650.00
Upside/Downside19.13%
GradeUndervalued
TypeValue
Dividend Yield1.76%

Risk Assessment

Beta0.59
Volatility34.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.